Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

6.0K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
6.0K
Diabetic Retinopathy01:27

Diabetic Retinopathy

55
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55
Diabetic Nephropathy01:28

Diabetic Nephropathy

32
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
32
Diabetic Neuropathy01:22

Diabetic Neuropathy

59
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
59

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Left atrial appendage closure with the AnchorMan or Watchman devices: 12-month results of the SAFE-PROTECT randomised trial.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026
Same author

Deciphering the role of cell-free extrachromosomal circular DNA in human heart failure.

Human genomics·2026
Same author

[Expression of Concern] Visfatin/PBEF/Nampt induces EMMPRIN and MMP‑9 production in macrophages via the NAMPT‑MAPK (p38, ERK1/2)‑NF‑κB signaling pathway.

International journal of molecular medicine·2026
Same author

The Multifaceted Role of Angiopoietin-Like Proteins in Coronary Heart Disease: From Molecular Mechanisms to Clinical Translation.

Journal of cardiovascular pharmacology·2026
Same author

Quadruple combination therapy with SGLT2i, GLP-1RA, ARNI and MRA in heart failure with preserved ejection fraction patients with type 2 diabetes mellitus: A prospective and observational cohort study.

Kardiologia polska·2026
Same author

High-throughput combinatorial screening of antiplatelet drugs for personalized medicine.

Microsystems & nanoengineering·2025

Related Experiment Video

Updated: May 2, 2026

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

1.5K

Targeting Rab7-Rilp Mediated Microlipophagy Alleviates Lipid Toxicity in Diabetic Cardiomyopathy.

Jiahan Ke1, Jianan Pan1, Hao Lin1

  • 1Department of Cardiology, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200001, China.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|June 5, 2024
PubMed
Summary

Diabetic cardiomyopathy involves lipid buildup in heart cells. Targeting the Rab7-Rilp pathway enhances lipid breakdown and may treat this condition.

Keywords:
diabetic cardiomyopathylipid toxicitylipophagy

More Related Videos

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

578
Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

165

Related Experiment Videos

Last Updated: May 2, 2026

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

1.5K
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

578
Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

165

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • Diabetic cardiomyopathy (DbCM) is a heart condition in diabetic patients, marked by diastolic dysfunction and heart failure.
  • Lipid droplet accumulation and subsequent lipotoxicity in cardiomyocytes are key drivers of DbCM.
  • Current treatments for DbCM are limited, necessitating exploration of novel therapeutic targets.

Purpose of the Study:

  • To investigate the role of lipophagy in DbCM and identify key molecular pathways involved in lipid droplet degradation.
  • To explore the potential of targeting the Rab7-Rilp pathway for therapeutic intervention in DbCM.

Main Methods:

  • Comparative analysis of lipophagy pathways (microlipophagy vs. macrolipophagy) in DbCM and control hearts.
  • RNA-sequencing and genetic manipulation (Rab7-CKO mice) to identify key modulators of lipophagy.
  • Biochemical assays to confirm Rab7 phosphorylation and its interaction with Rilp.
  • Pharmacological activation of Rab7 using ML-098 in DbCM mouse models.

Main Results:

  • Lipid droplet accumulation and lipotoxicity are confirmed in DbCM hearts.
  • The microlipophagy pathway, not macrolipophagy, is activated in DbCM.
  • Rab7 is identified as a crucial modulator of microlipophagy, with its phosphorylation at Tyrosine 183 facilitating Rilp recruitment and lysosomal lipid degradation.
  • Pharmacological activation of Rab7 with ML-098 increased Rilp levels and improved cardiac function in DbCM mice.

Conclusions:

  • Rab7-Rilp-mediated microlipophagy is a critical pathway for degrading lipid droplets in DbCM.
  • This pathway represents a promising therapeutic target for mitigating lipid toxicity and restoring cardiac function in diabetic cardiomyopathy.